Insuline Medical Ltd. is a Public Israeli company TASE – INSL focused on improving the performance of current insulin treatment methods, by trying to better approximate human physiology. Even with today’s rapid acting insulin analogs, there is a gap of at least one hour between bolus insulin injection and its peak in the blood system.


  • 45% less Hypoglycemia on average Blood sugar variability after meals is reduced.
  • 28% reduction in prandial Insulin on average Normoglycemia with less risk.
  • Easy to use User satisfaction with high compliance.


InsuPad® Gil
Introducing InsuPad®
InsuPad® IFU
InsuPad® Neomi
InsuPad® Uri
Powered by